The State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, #54 Xianlie South Road, Guangzhou, Guangdong, 510060, China.
Adv Sci (Weinh). 2022 May;9(14):e2105539. doi: 10.1002/advs.202105539. Epub 2022 Mar 16.
The methyltransferase EZH2 plays an important role in regulating chromatin conformation and gene transcription. Phosphorylation of EZH2 at S21 by AKT kinase suppresses its function. However, protein phosphatases responsible for the dephosphorylation of EZH2-S21 remain elusive. Here, it is demonstrated that EZH2 is highly expressed in the ocular lens, and AKT-EZH2 axis is important in TGFβ-induced epithelial-mesenchymal transition (EMT). More importantly, it is identified that MYPT1/PP1 dephosphorylates EZH2-S21 and thus modulates its functions. MYPT1 knockout accelerates EMT, but expression of the EZH2-S21A mutant suppresses EMT through control of multiple families of genes. Furthermore, the phosphorylation status and gene expression modulation of EZH2 are implicated in control of anterior subcapsular cataracts (ASC) in human and mouse eyes. Together, the results identify the specific phosphatase for EZH2-S21 and reveal EZH2 dephosphorylation control of several families of genes implicated in lens EMT and ASC pathogenesis. These results provide important novel information in EZH2 function and regulation.
甲基转移酶 EZH2 在调节染色质构象和基因转录中发挥重要作用。AKT 激酶对 EZH2 的 S21 进行磷酸化会抑制其功能。然而,负责 EZH2-S21 去磷酸化的蛋白磷酸酶仍不清楚。本文证明 EZH2 在眼部晶状体中高表达,AKT-EZH2 轴在 TGFβ 诱导的上皮-间充质转化(EMT)中很重要。更重要的是,确定了 MYPT1/PP1 去磷酸化 EZH2-S21 并调节其功能。MYPT1 敲除加速 EMT,但 EZH2-S21A 突变体的表达通过控制多个基因家族抑制 EMT。此外,EZH2 的磷酸化状态和基因表达调控与人类和小鼠眼睛前囊下白内障(ASC)的控制有关。总之,这些结果确定了 EZH2-S21 的特定磷酸酶,并揭示了 EZH2 去磷酸化对参与晶状体 EMT 和 ASC 发病机制的多个基因家族的控制。这些结果为 EZH2 的功能和调控提供了重要的新信息。